Aug 7, 2026 · 6 min
Data-center demand lifts Kingspan as tariffs pressure Daimler Truck
Kingspan Soars, Daimler Truck Slumps, Genmab Jumps
The episode shows how infrastructure demand, trade exposure, and biotech execution are reshaping European stock stories.
- 1Kingspan rallies as data-center construction strengthens demand for its building materials.
- 2Daimler Truck plans a new US plant to reduce the risks posed by North American tariffs.
- 3Genmab reports a strong second quarter and raises its full-year outlook ahead of clinical trial catalysts.
Don't miss
Genmab’s strong second quarter and upgraded full-year outlook stand out as the clearest positive earnings surprise in the report.
The brief
Bloomberg’s Caroline Hepker, Charles Capel, and Chloe Melley examine three European stock moves driven by sharply different forces: construction demand, tariff risk, and biotech momentum.
Kingspan’s rally reflects the pull of data-center construction, showing how investment in digital infrastructure is feeding through to a building-materials company.
Daimler Truck is taking a defensive approach to North American tariffs, planning a new US plant to reduce its exposure to trade barriers.
Genmab provides the strongest growth signal in the group: a solid second quarter, upgraded full-year guidance, and clinical trial catalysts still ahead.
Together, the moves show why European equities cannot be read through one market narrative: company-specific exposure is setting the direction.
What was said on this episode
8 statements · 5 positive · 3 negative
Kingspan’s data-center exposure is driving its stock higher.
“it does have a big exposure to data center construction and that is what is really driving that stock this morning”
Listen at 1:06
Kingspan may announce a deal soon.
“We could probably hear some something from this company about a potential deal coming soon.”
Listen at 2:10
Tariffs are causing weakness in Daimler Truck’s North American market.
“a lot of weakness in the North American truck truck market because of those tariffs”
Listen at 2:33
Daimler Truck faces a 25% duty on heavy trucks made in Mexico for the US.
“it makes a significant share of its trucks bound for the US in Mexico. So it's, it's subject to the 25% duty on those heavy truck imports”
Listen at 2:42
Daimler Truck plans a US plant to reduce tariff exposure.
“it said that it was planning on building a new manufacturing plant in the US to reduce some of that tariff exposure”
Listen at 2:56
Daimler Truck has weak orders and soft guidance.
“The orders were quite weak, the guidance is quite soft.”
Listen at 3:14
GenmAb exceeded revenue and profit expectations and raised its annual outlook.
“GenmAb makes antibody therapeutics, so reported better than expected revenue, better than expected profit for the second quarter and it also boosted its outlook for the year.”
Listen at 3:30
GenmAb’s lymphoma program could represent a $600 million opportunity in 2035.
“that could be a $600 million commercial opportunity in 2035, according to Bloomberg Intelligence”
Listen at 4:02
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
North AmericaListen to the full episode and explore every guest, topic, and moment on PodLume.